Hasil Pencarian - Chengcheng Gong
- Menampilkan 1 - 16 hasil dari 16
-
1
-
2
-
3
-
4
Clinicopathological characteristics, evolution, treatment pattern and outcomes of hormone-receptor-positive/HER2-low metastatic breast cancer oleh Shuhui You, Shuhui You, Chengcheng Gong, Chengcheng Gong, Yi Li, Yizhao Xie, Yumeng Li, Yumeng Li, Yannan Zhao, Yannan Zhao, Biyun Wang, Biyun Wang
Diterbitkan 2023-10-01
Artikel -
5
Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2− Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study oleh Yannan Zhao, Cheng Liu, Yingjian Zhang, Chengcheng Gong, Yi Li, Yizhao Xie, Bingrui Wu, Zhongyi Yang, Biyun Wang
Diterbitkan 2018-09-01
Artikel -
6
A multicenter analysis of treatment patterns and clinical outcomes of subsequent therapies after progression on palbociclib in HR+/HER2− metastatic breast cancer oleh Yi Li, Wei Li, Chengcheng Gong, Yabin Zheng, Quchang Ouyang, Ning Xie, Qing Qu, Rui Ge, Biyun Wang
Diterbitkan 2021-06-01
Artikel -
7
DNA methylation suppresses chitin degradation and promotes the wing development by inhibiting Bmara-mediated chitinase expression in the silkworm, Bombyx mori oleh Guanfeng Xu, Yangqin Yi, Hao Lyu, Chengcheng Gong, Qili Feng, Qisheng Song, Xuezhen Peng, Lin Liu, Sichun Zheng
Diterbitkan 2020-09-01
Artikel -
8
Heterogeneity derived from 18F‐FDG PET/CT predicts immunotherapy outcome for metastatic triple‐negative breast cancer patients oleh Yizhao Xie, Cheng Liu, Yannan Zhao, Chengcheng Gong, Yi Li, Shihui Hu, Shaoli Song, Xichun Hu, Zhongyi Yang, Biyun Wang
Diterbitkan 2022-05-01
Artikel -
9
Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study oleh Yi Li, Chengcheng Gong, Qianyi Lu, Zhaochun Zhou, Ting Luo, Wei Li, Gang Li, Rui Ge, Fei Xu, Biyun Wang
Diterbitkan 2020-03-01
Artikel -
10
ER status conversion and subsequent treatment: an assessment of negative ER expression detected by 18F-FES PET in metastatic breast cancer patients with ER-positive primary tumors oleh Shuhui You, Yizhao Xie, Mengjing Ji, Cheng Liu, Yannan Zhao, Chengcheng Gong, Shihui Hu, Yumeng Li, Zhongyi Yang, Biyun Wang
Diterbitkan 2023-12-01
Artikel -
11
Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data oleh Chengcheng Gong, Yizhao Xie, Yannan Zhao, Yi Li, Jian Zhang, Leiping Wang, Jun Cao, Zhonghua Tao, Xichun Hu, Biyun Wang
Diterbitkan 2022-12-01
Artikel -
12
-
13
A preliminary study of 18F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel oleh Chengcheng Gong, Zhongyi Yang, Yifei Sun, Jian Zhang, Chunlei Zheng, Leiping Wang, Yongping Zhang, Jing Xue, Zhifeng Yao, Herong Pan, Biyun Wang, Yingjian Zhang
Diterbitkan 2017-07-01
Artikel -
14
Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases oleh Yizhao Xie, Chengcheng Gong, Jian Zhang, Leiping Wang, Jun Cao, Zhonghua Tao, Ting Li, Yannan Zhao, Yi Li, Shihui Hu, Biyun Wang, Xichun Hu
Diterbitkan 2021-11-01
Artikel -
15
Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients oleh Zhonghua Tao, Zhonghua Tao, Ting Li, Ting Li, Zhe Feng, Zhe Feng, Chang Liu, Chang Liu, Yilin Shao, Yilin Shao, Mingyu Zhu, Mingyu Zhu, Chengcheng Gong, Chengcheng Gong, Biyun Wang, Biyun Wang, Jun Cao, Jun Cao, Leipin Wang, Leipin Wang, Yiqun Du, Yiqun Du, Analyn Lizaso, Bing Li, Jian Zhang, Jian Zhang, Xichun Hu, Xichun Hu
Diterbitkan 2020-06-01
Artikel -
16
Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective study oleh Yannan Zhao, Ning Xie, Wei Li, Wenyan Chen, Zheng Lv, Yabing Zheng, Tao Sun, Jieqiong Liu, Jian Zhang, Shihui Hu, Yajun Wang, Chengcheng Gong, Yi Li, Yizhao Xie, Rui Ge, Fei Xu, Biyun Wang
Diterbitkan 2021-07-01
Artikel